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Background: A considerable interest has been drawn to potential protective effects of bilirubin against oxidative
stress-related diseases. Smoking is known to be associated with lower concentrations of serum bilirubin, but other
behavioral correlates of serum bilirubin have not been well studied. In this cross-sectional study, we examined the
associations of behavioral and clinical factors with serum total bilirubin in Japanese men and women.
Method: The study subjects comprised of 4802 men and 6414 women aged 49–76 years who participated in the
baseline survey of an ongoing cohort study on lifestyle-related diseases in Fukuoka, Japan. With consideration to
time of the day of blood sampling and fasting hours, the associations with smoking, alcohol intake, body mass
index, physical activity, coffee, tea, blood pressure, glycated hemoglobin (HbA1c), HDL cholesterol and non-HDL
cholesterol with serum bilirubin were evaluated by analysis of covariance and multiple linear regression analysis.
Results: While smoking was negatively associated with serum bilirubin, alcohol consumption was positively associated
with serum bilirubin in both men and women. Coffee consumption was associated with lower bilirubin concentrations
in both sexes. In the multiple linear regression analysis, HDL cholesterol was positively and HbA1c was negatively
associated with bilirubin in both men and women, and the associations were more evident in women.
Conclusion: Smoking, alcohol use and coffee consumption were important behavioral correlates of serum bilirubin in
Japanese men and women. Serum HDL cholesterol was a measurable clinical correlate of bilirubin in women.
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A considerable interest has been drawn to potential pro-
tective effects of bilirubin against oxidative stress-related
diseases [1-4]. High bilirubin concentrations have been
related to decreased risk of coronary artery disease
[1-4] while evidence remains controversial as regards
the associations with stroke and cancer risk [2,4]. High
bilirubin concentrations may also be protective against the
deterioration of glucose metabolism [5]. Serum bilirubin
concentrations are low in women than in men [6-8],
and seem to decrease with age in adulthood at least in
men [6,7]. Smoking is known to be associated with
lower concentrations of serum bilirubin [6-9], but other* Correspondence: mayatnkmayatnk@gmail.com
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reproduction in any medium, provided the orbehavioral correlates of serum bilirubin have not been
well studied.
In epidemiological studies on bilirubin and disease risk,
the investigators examined the associations of behavioral
and clinical factors with serum bilirubin mostly in the
univariate analysis [6,7,10-12] or in the analysis controlling
for demographic factors only [12,13] in order to explore
potential confounders. Only two studies performed the
multivariate analysis on serum bilirubin in relation to
cardiovascular risk factors [14,15]. A negative association
between body mass index (BMI) and serum bilirubin
was observed in several [7,10-13], but not all [6,14,15],
of these studies. Few studies suggested that alcohol use
was related to higher concentrations of serum bilirubin
[7,12], but such an association was not found in other
studies [11,14]. It was reported that high-density lipo-
protein (HDL) cholesterol was positively correlated
with serum bilirubin while total or non-HDL cholesterolLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the findings are not consistent [10,15].
In this cross-sectional study, we examined the associa-
tions of behavioral and clinical factors with serum bilirubin
in Japanese men and women. Behavioral factors included
coffee and tea consumption in addition to smoking, al-
cohol use, BMI, and physical activity. Coffee and green
tea are abundant in antioxidant polyphenols, and the
consumption of these beverages has been implicated as
protective against various diseases [18,19].
Methods
Study subjects
The study subjects comprised of men and women who
participated in the baseline survey of an on-going cohort
study on lifestyle-related diseases. Residents of the East
Ward of Fukuoka City aged 50 to 74 years were invited
to participate in the study by mail. All participants were
informed of the details of the survey and gave written
informed consent prior to their participation in the study.
The study was approved by the Ethics Committee of the
Kyushu University Faculty of Medical Sciences.
During the period from February 2004 to August 2007,
a total of 12948 subjects participated in the baseline
survey, with a participation rate of 24%. Age of the
participants at the time of survey ranged from 49 to
76 years. Stored serum samples of 12942 participants
were available for the measurement of bilirubin. We
excluded 1548 participants who were under medical
care for coronary artery disease (n = 533), stroke (n = 251),
arteriosclerosis obliterance (n = 36), chronic liver disease
(n = 252), cancer (n = 496), alcohol abuse (n = 4) or
who had aspartate aminotransferase (AST) or alanine
aminotransferase (ALT) greater than 3-fold of the upper
limit of the normal range, i.e., > 120 U/L (n = 59), total
bilirubin > 3 mg/dL (n = 3), creatinine > 2 mg/dL (n = 44).
Additionally excluded were 160 subjects who reported
a prior history of coronary artery disease (n = 31) or
stroke (n = 131) without current medical care. We further
excluded 18 participants with missing values on the
covariates under consideration. The remaining 11216
subjects (4802 men and 6414 women) were included in
the present analysis.
Baseline survey
At the baseline survey, each participant completed a
self-administered questionnaire and underwent measure-
ments of blood pressure, height (cm) and body weight
(kg). Fasting or nonfasting venous blood was drawn.
The questionnaire inquired about smoking habits, alcohol
consumption, physical activity, dietary intake, disease
history, and use of selected drugs and supplements.
Details of the questionnaire have been described pre-
viously [20,21]. In brief, ever-smoking was defined ashaving smoked at least one cigarette per day for one
or more years. Past and current smokers reported the
number of cigarettes smoked per day and years of
smoking. Ever-alcohol use was defined as having drunk
alcoholic beverages at least once a week for one or more
years. Past alcohol use was separated from lifelong
alcohol-abstinence. Current alcohol drinkers reported
consumption frequencies and amounts of 5 alcoholic
beverages on average in the past year, and the amount
of ethanol consumed per day was calculated. Questions
on physical activity ascertained work-related (4 types)
and leisure-time (3 types) physical activities over the
previous year. With consideration to intensity in terms
of metabolic equivalent (MET) and amount of time for
each physical activity, MET-hours were calculated for
work-related and leisure-time physical activity separately.
BMI was calculated as weight (kg) divided by squared
height (m2). The time of the last meal prior to the survey
and the time of blood drawing were recorded.
Systolic and diastolic blood pressure were measured
by an automated digital device (HEM-707, OMRON,
Kyoto) after at least five minutes of sitting position.
Blood pressure was taken twice with an interval of at
least one-minute, and the second reading was used in
this study.
Laboratory measurements
Serum samples stored at −80°C were used for the deter-
mination of total, unconjugated and conjugated bilirubin
concentrations. Measurements of bilirubin were performed
by the using absorptiometric assay with chemical oxi-
dation by vanadic acid [22] at an external laboratory
(SRL, Hachiohji, Japan). Total bilirubin was used in the
present study. HbA1c was measured at the above-described
laboratory by using the latex agglutination immunoassay
[23]. As for eight items of serum biochemistry including
AST, ALT, total and HDL cholesterol and creatinine,
recorded information was referred to if these measure-
ments had been done in the past year. When recorded
information was not available, 5 mL of venous blood
was taken for the measurements, and serum samples
frozen in dry ice were shipped to the above-mentioned
external laboratory.
Statistical analyses
The distribution of serum total bilirubin was skewed to
the right side, and the values were always transformed
to the natural logarithms in the analysis. Fasting status
[24,25] and hours of the day [26] are known to affect
bilirubin concentrations. Thus we did a preliminary
analysis on fasting hours and the time of blood drawing
in relation to bilirubin concentrations to determine the
category of these factors in the main analysis. Based on
the patterns shown in Figure 1, the fasting hours were
Figure 1 Geometric means of serum total bilirubin according to hours of fasting (left panel) and time of blood drawing (right panel) in
men (n = 4802) and women (n = 6414). Adjusted for age and either time of blood drawing or hours of fasting. P < 0.0001 for both men and
women in both models.
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blood drawing was classified into < 12, 12–14 and ≥
14 hours. Bilirubin concentrations also differed slightly by
season as reported previously [27]. With adjustment for
age, fasting hours and time of blood drawing, geometric
means for winter (December to February), spring (March
to May), summer (June to August) and autumn (September
to November) were 0.53, 0.53, 0.56 and 0.55 mg/dL respect-
ively among men (analysis of covariance P = 0.0005), and
0.46, 0.46, 0.48, and 0.48 mg/dL respectively among women
(P = 0.01). Seasons were thus collapsed into 2 categories
(winter/spring and summer/autumn).
As clinical covariates, hypertension, type 2 diabetes
mellitus and elevated non-HDL cholesterol were defined.
Hypertension was defined if systolic blood pressure was ≥
140 mmHg or diastolic blood pressure was ≥ 90 mmHg
or if antihypertensive drugs were used. Type 2 diabetes
mellitus was defined if individuals reported current
medication for diabetes mellitus or if HbA1c was ≥
6.5% [28]. Elevated non-HDL cholesterol was defined if
non-HDL cholesterol was ≥ 170 mg/dL [29].
Analysis of covariance was used to calculate adjusted
geometric means and 95% confidence intervals (CI) of
total bilirubin concentrations according to smoking (never,
past and current smokers with < 15, 15–29 and ≥ 30
cigarettes/day), alcohol intake (never, past and current
drinkers with a consumption of < 25, 25–49 and ≥ 50 g of
alcohol/day), BMI (< 22.5, 22.5–24.9, 25.0–27.4 and ≥
27.5 kg/m2), job-related and leisure-time physical activity
(sex-specific quartiles each), coffee (0, < 1, 1–3, 4–6 and ≥
7 cups/day), tea (< 1, 1–3, 4–6, 7–9 and ≥ 10 cups/day),
hypertension, type 2 diabetes mellitus and elevated non-HDL. Three models were used in the statistical adjust-
ment. The first model included only age (continuous
variable) as covariate; the second model used age, hours
of fasting (< 4, 4–7 and ≥ 8 hours), time of blood drawing
(< 12, 12–14 and ≥ 14 hours), and season (winter/spring
and summer/autumn) as covariates; and the third model
included all of the above-mentioned lifestyle and clinical
covariates as well as those used in the model 2. In the
analysis of covariance, indicator variables were used for
each categorical factor except for a factor of interest. The
Dunnett method was used for the two-group comparison
with the lowest category as referent.
Multiple linear regression analysis was employed in
the analysis using continuous variables for diastolic
blood pressure, non-HDL cholesterol, HDL cholesterol
and HbA1c and also including drug uses as covariates.
Categorical covariates were represented by indicator vari-
ables. The relative contribution of a specific covariate to
the variation in bilirubin concentrations was expressed by
the proportion of the partial R2 to the overall R2 estimated
in the model including all of the covariates. The partial R2
was estimated as the difference in the R2 statistics between
the full model and a model including all the covariates
except the specified variable. Because the number of the
subjects was fairly large, two-tailed P value < 0.01 was
considered as statistically significant. All statistical analyses
were carried out by using SAS version 9.2 (SAS Institute,
Cary, NC).
Results
Mean ages were 62.5 years (SD 6.8 years) in men and
62.0 years (SD 6.7 years) in women. Geometric mean
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men and 0.47 mg/dL in women.
With respect to each of the lifestyle and clinical factors
under study, the geometric means of serum bilirubin
adjusted for age, postprandial hours, time of blood
drawing and season (model 2) were almost the same as
the age-adjusted geometric means (model 1). Thus age-
adjusted and multivariate-adjusted geometric means
(model 3) are shown for ease of presentation.
In men (Table 1), serum bilirubin was progressively
lower with increasing amounts of cigarettes per day while
alcohol consumption was strongly positively associated
with serum bilirubin. In women (Table 2), serum bilirubin
was also lower in current smokers, but there was no
dose-relationship with the amount of cigarettes. Women
also showed a positive association between alcohol
consumption and bilirubin. Past alcohol drinkers had
rather lowered concentrations of bilirubin in women.
BMI was unrelated to serum bilirubin in men, but women
showed statistically, significantly lower concentrations
in the highest BMI category (≥ 27.5 kg/m2) as compared
with the lowest category.
Age-adjusted, but not multivariate-adjusted, geometric
means of serum bilirubin were higher in men with
higher levels of leisure-time physical activity. Neither
age-adjusted nor multivariate-adjusted means showed
such a measurable association in women. On the other
hand, job-related physical activity did not show any
association with bilirubin concentrations in either men
or women. In both men and women, with an exception
of women consuming ≥7 cups of coffee, serum bilirubin
was markedly lower with increasing consumption of cof-
fee. The negative association between coffee and bilirubin
was more evident in men than in women. The consump-
tion of tea was unrelated to serum bilirubin in both sexes.
In men, but not in women, type 2 diabetes mellitus and
elevated non-HDL cholesterol were associated with lower
bilirubin concentrations. Hypertension was not associated
with serum bilirubin in either men or women.
We evaluated whether deterioration of liver function
accounted for the positive association between alcohol
and serum bilirubin. Medians of serum AST were 22
U/L (interquartile range [IQR] 19–27 U/L) in men
and 21 U/L (19–25) in women, and those of serum
ALT were 21 U/L (16–28 U/L) in men and 17 U/L
(14–22 U/L) in women. Alcohol consumption was
positively correlated with AST in men, and more weakly
in women. Spearman correlation coefficients with alco-
hol consumption (excluding past drinkers) were 0.18
for AST and 0.01 for ALT in men, and 0.04 for AST
and 0.002 for ALT in women. In men, with adjustment
for the covariates except alcohol use in Table 1, geomet-
ric means of serum bilirubin for the first to fourth quar-
tile categories of AST were 0.52, 0.54, 0.55 and0.56 mg/dL (P < 0.0001), and those for the ALT cat-
egories were 0.53, 0.54, 0.54 and 0.56 (P = 0.02). Neither
AST nor ALT was associated with bilirubin in women.
With additional adjustment for AST (quartile categor-
ies), the multivariate-adjusted geometric means of serum
bilirubin according to alcohol consumption (never, past,
<25, 25–49 and ≥ 50 g/day) were 0.51, 0.50, 0.54. 0.56 and
0.58 U/L (P < 0.0001) in men and exactly the same as
shown in Table 2 in women (P < 0.0001). The adjust-
ment for ALT did not change the association between
alcohol and bilirubin in either men or women (data not
shown).
We performed a multiple linear regression analysis
using continuous variables for diastolic blood pressure,
non-HDL cholesterol, HDL cholesterol and HbA1c and
also including drug uses as covariates (Table 3). Non-HDL
cholesterol and use of cholesterol-lowering drug were
negatively associated with serum bilirubin in men, but
not in women. On the other hand, HDL cholesterol was
strongly, positively associated with bilirubin in both men
and women. Both genders showed a negative association
between HbA1c and bilirubin. The associations with HDL
cholesterol and HbA1c were more evident in women.
The covariates in the multiple linear regression ac-
counted for 12.9% of the variation of bilirubin con-
centrations in men and for 10.3% of that in women.
The contribution of time of the day at blood sam-
pling and fasting hours was relatively large, especially
in women (Table 4). Comparatively, the seasonal vari-
ation that serum bilirubin was lower in winter/spring
made a much smaller contribution. Smoking showed the
largest contribution to the variation of bilirubin in
men, and the proportion ascribed to smoking was much
smaller in women. Alcohol use and coffee consumption
were modest, but discernible contributors in men and
women. The contribution of the other behavioral factors
was negligible or at most minimal. Of the clinical corre-
lates, HDL cholesterol was the most important covariate
in women. The effect of non-HDL cholesterol and use of
cholesterol-lowering was almost negligible in women. In
men, non-HDL cholesterol, HDL cholesterol and use of
cholesterol-lowering drug each showed a small contribu-
tion to almost the same extent. The contribution of
HbA1c was less important as determinant of bilirubin
concentrations in men.Discussion
The present multivariate analysis showed that smoking
and alcohol consumption were independent correlates
of serum bilirubin in both men and women. A notable
finding was that coffee consumption was associated with
lower bilirubin concentrations in both sexes. Serum biliru-
bin showed a positive association with HDL cholesterol
Table 1 Serum total bilirubin (mg/dL) according to behavioral and clinical factors in men
Variable Category n Geometric mean (95% CI)
Age-adjusted Multivariate-adjusteda
Smoking (cigarettes/day) Never 1245 0.58 (0.57−0.59) 0.58 (0.57−0.59)
Past 2038 0.57 (0.56−0.58) 0.57 (0.56−0.58)
< 15 262 0.51 (0.49−0.54)h 0.51 (0.49−0.53)h
15–29 873 0.48 (0.47−0.49)h 0.48 (0.47−0.49)h
≥ 30 384 0.47 (0.45−0.49)h 0.47 (0.45−0.49)h
P-valueb <0.0001 <0.0001
Alcohol intake (g/day) Never 1020 0.50 (0.49−0.51) 0.50 (0.49−0.52)
Past 301 0.49 (0.47−0.51) 0.49 (0.47−0.52)
< 25 1472 0.55 (0.54−0.56)h 0.54 (0.53−0.55)h
25–49 1229 0.57 (0.55−0.58)h 0.56 (0.55−0.58)h
≥ 50 780 0.58 (0.57−0.60)h 0.59 (0.57−0.60)h
P-valueb <0.0001 <0.0001
Body mass index (kg/m2) < 22.5 1663 0.54 (0.53−0.55) 0.54 (0.53−0.55)
22.5–24.9 1780 0.54 (0.53−0.55) 0.54 (0.53−0.55)
25.0–27.4 1004 0.56 (0.54−0.57) 0.55 (0.54−0.56)
≥ 27.5 355 0.54 (0.52−0.56) 0.54 (0.52−0.56)
P-valueb 0.14 0.57
Job-related physical activityc Q1 1471 0.54 (0.53−0.55) 0.55 (0.54−0.56)
Q2 1104 0.55 (0.53−0.56) 0.55 (0.53−0.56)
Q3 1087 0.55 (0.53−0.56) 0.54 (0.53−0.55)
Q4 1140 0.53 (0.52−0.55) 0.53 (0.52−0.54)
P-valueb 0.40 0.23
Leisure-time physical activityc Q1 1112 0.52 (0.51−0.54) 0.54 (0.52−0.55)
Q2 1312 0.54 (0.53−0.55) 0.54 (0.53−0.55)
Q3 1178 0.55 (0.53−0.56) 0.54 (0.53−0.55)
Q4 1200 0.56 (0.55−0.57)h 0.55 (0.54−0.56)
P-valueb 0.0007 0.34
Coffee (cups/d) 0 814 0.58 (0.57−0.60) 0.57 (0.55−0.58)
< 1 1250 0.57 (0.56−0.58) 0.56 (0.55−0.57)
1–3 2149 0.53 (0.53−0.54)h 0.54 (0.53−0.55)g
4–6 497 0.48 (0.46−0.50)h 0.51 (0.49−0.52)h
≥ 7 92 0.44 (0.41−0.48)h 0.48 (0.45−0.52)h
P-valueb < 0.0001 < 0.0001
Tea (cups/d) < 1 638 0.54 (0.52−0.56) 0.54 (0.52−0.56)
1–3 1969 0.55 (0.54−0.56) 0.55 (0.54−0.56)
4–6 1379 0.55 (0.53−0.56) 0.54 (0.53−0.56)
7–9 483 0.52 (0.50−0.54) 0.52 (0.51−0.54)
≥10 333 0.55 (0.52−0.57) 0.55 (0.53−0.57)
P-valueb 0.18 0.23
Hypertensiond (−) 1859 0.54 (0.53−0.55) 0.55 (0.54−0.56)
(+) 2943 0.54 (0.54−0.55) 0.54 (0.53−0.55)
P-valueb 0.34 0.20
Type 2 DMe (−) 4321 0.55 (0.54−0.55) 0.54 (0.54−0.55)
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Table 1 Serum total bilirubin (mg/dL) according to behavioral and clinical factors in men (Continued)
(+) 481 0.52 (0.50−0.53) 0.52 (0.51−0.54)
P-valueb 0.004 0.03
Elevated non-HDL cholesterolf (−) 3554 0.55 (0.55−0.56) 0.55 (0.54−0.56)
(+) 1248 0.51 (0.50−0.53) 0.52 (0.51−0.53)
P-valueb < 0.0001 < 0.0001
CI, confidence interval; DM, diabetes mellitus; HDL, high-density lipoprotein.
aAdjusted for age (year), hours of fasting (< 4, 4–7 and ≥ 8 hours), time of blood drawing (< 12, 12–14 and ≥ 14 hours), season (winter/spring and summer/
autumn) and the listed factors by analysis of covariance.
bOverall difference.
cQuartile category of MET-hours per day (job-related physical activity) or per week (leisure-time physical activity).
dSystolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or use of antihypertensive drugs.
eHbA1c ≥ 6.5% or medication for diabetes mellitus.
fNon-HDL cholesterol ≥ 170 mg/dL.
gP < 0.01 and h P < 0.001 as compared with the lowest category (Dunnett method).
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more evident in women than in men.
Smoking has consistently been related to decreased levels
of serum bilirubin [6-10,12,14-16]. It is postulated that
bilirubin is consumed in response to increased oxidative
stress due to smoking [8,9], but the exact mechanisms
remain unclear. The present findings on smoking and
bilirubin add to evidence for a negative association be-
tween smoking and serum bilirubin. The lack of a dose–
response relationship in women was probably ascribed to
chance due to fewer heavy smokers. Alternatively, female
smokers may have inhaled less as compared with male
smokers.
Literature on behavioral factors other than smoking is
limited. While earlier studies found no clear association
between alcohol drinking and serum bilirubin in either
univariate or multivariate analysis [10,11,14], recent large
studies suggested higher concentrations of serum bilirubin
among male alcohol drinkers in Korea [12] and male
and female in the United Kingdom [7]. The latter findings
were also based on the univariate analysis alone [7,12]. In
the present population, alcohol consumption was strongly
associated with elevated concentrations of serum bilirubin
in both men and women. It should be noted that a positive
association between alcohol use and bilirubin among
women was accentuated in the multivariate analysis while
the association did not differ in the age-adjusted and
multivariate-adjusted means in men. Alcohol consumption
is protective against atherosclerosis, partly by increasing
HDL cholesterol [30]. Subjects with known atherosclerotic
diseases were excluded in the present analysis, but serum
bilirubin may have reflected the extent of atherosclerotic
lesions although statistical adjustment was made for
important risk factors of atherosclerosis. It may be
argued that deterioration of liver function underlies the
positive association between alcohol and bilirubin. In
fact, serum AST and ALT were positively associated withserum bilirubin in men, but not in women. However,
the positive association between alcohol and bilirubin
in men was not materially attenuated after adjustment
for AST or ALT. Thus the alcohol-bilirubin association
does not seem to be mediated by liver function
deterioration.
Coffee and tea are the major sources of polyphenol
intake in Japan [31]. Coffee is abundant with antioxidant
polyphenols such as chlorogenic and caffeic acids while
catechins are an antioxidant polyphenol in tea. Previously,
coffee consumption was shown to be negatively associated
with serum bilirubin as well as with serum activities of
liver enzymes in a cross-sectional study in Italy [32].
Coffee consumption has consistently been associated
with lower levels of ALT and AST [33], as observed in
the present study population as well [34]. However, the
effect of coffee on serum bilirubin seems to be mechanis-
tically different from that on liver enzymes. As reported
in the Korean study [12], serum bilirubin was minimally
correlated or almost uncorrelated with ALT or AST;
Spearman correlation coefficients were 0.06 for ALT
and 0.11 for AST in men and −0.01 for ALT and 0.03 for
AST in women. Bilirubin is produced by heme oxygenase,
especially by heme oxygenase 1 induced in response to
oxidative stress and other stimuli, and is excreted into
bile via conjugation by uridine 5'-diphospho-glucuro-
nosyltransferase (UGT) 1A1 [2]. Coffee compounds may
affect the enzymes involved in the production or conju-
gation of bilirubin. Interestingly, in vitro and in vivo
experiments showed that coffee infusion enhanced the
expression of the UGT1A genes including the UGT1A1
gene, independent of caffeine content [35]. However,
such an effect of coffee on the UGT1A1 gene was not
observed in a different experimental study [36]. It de-
serves further research whether the negative association
between coffee consumption and serum bilirubin is due
to enhanced glucuronidation.
Table 2 Serum total bilirubin (mg/dL) according to behavioral and clinical factors in women
Variables Category N Geometric mean (95% CI)
Age-adjusted Multivariate-adjusteda
Smoking (cigarettes/day) Never 5685 0.47 (0.47−0.48) 0.47 (0.47−0.48)
Past 331 0.46 (0.44−0.47) 0.46 (0.44−0.48)
< 15 178 0.42 (0.39−0.44)h 0.41 (0.39−0.44)h
15–29 195 0.40 (0.38−0.42)h 0.40 (0.38−0.42)h
≥ 30 25 0.44 (0.38−0.51) 0.43 (0.37−0.50)
P-valueb < 0.0001 < 0.0001
Alcohol intake (g/day) Never 4523 0.47 (0.46−0.47) 0.46 (0.46−0.47)
Past 158 0.43 (0.41−0.46) 0.44 (0.42−0.47)
< 25 1499 0.48 (0.47−0.48) 0.48 (0.47−0.49)
25–49 189 0.51 (0.48−0.53) 0.52 (0.50−0.55)h
≥ 50 45 0.52 (0.47−0.58) 0.56 (0.50−0.62)g
P-valueb 0.0001 < 0.0001
Body mass index (kg/m2) < 22.5 3361 0.47 (0.47−0.48) 0.47 (0.47−0.48)
22.5–24.9 1810 0.47 (0.46−0.48) 0.47 (0.46−0.48)
25.0–27.4 803 0.46 (0.45−0.47) 0.46 (0.45−0.48)
≥ 27.5 440 0.43 (0.42−0.45)h 0.44 (0.42−0.45)h
P-valueb < 0.0001 < 0.0001
Job-related physical activityc Q1 1396 0.46 (0.45−0.47) 0.46 (0.46−0.47)
Q2 2011 0.47 (0.46−0.48) 0.47 (0.46−0.47)
Q3 1373 0.47 (0.46−0.48) 0.46 (0.46−0.47)
Q4 1634 0.48 (0.47−0.48) 0.48 (0.47−0.49)
P-valueb 0.16 0.12
Leisure-time physical activityc Q1 1684 0.45 (0.45−0.46) 0.46 (0.45−0.47)
Q2 1720 0.48 (0.47−0.49)h 0.48 (0.47−0.48)g
Q3 1375 0.47 (0.46−0.48) 0.47 (0.46−0.48)
Q4 1635 0.47 (0.47−0.48)g 0.47 (0.46−0.48)
P-valueb 0.0006 0.02
Coffee (cups/d) 0 982 0.49 (0.48−0.51) 0.49 (0.48−0.50)
< 1 1725 0.48 (0.47−0.49) 0.48 (0.47−0.49)
1–3 3159 0.46 (0.46−0.47)h 0.46 (0.46−0.47)h
4–6 484 0.43 (0.42−0.44)h 0.44 (0.42−0.45)h
≥ 7 64 0.46 (0.42−0.50) 0.46 (0.42−0.50)
P-valueb < 0.0001 < 0.0001
Tea (cups/d) < 1 440 0.46 (0.44−0.47) 0.47 (0.45−0.48)
1–3 1856 0.47 (0.46−0.48) 0.47 (0.46−0.48)
4–6 2202 0.47 (0.46−0.48) 0.47 (0.46−0.48)
7–9 1162 0.47 (0.46−0.48) 0.47 (0.46−0.48)
≥ 10 754 0.48 (0.46−0.49) 0.47 (0.46−0.48)
P-valueb 0.52 0.95
Hypertensiond (−) 3465 0.47 (0.46−0.47) 0.47 (0.46−0.47)
(+) 2949 0.47 (0.47−0.48) 0.47 (0.47−0.48)
P-valueb 0.25 0.29
Type 2 DMe (−) 6151 0.47 (0.47−0.47) 0.47 (0.47−0.47)
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Table 2 Serum total bilirubin (mg/dL) according to behavioral and clinical factors in women (Continued)
(+) 263 0.45 (0.43−0.47) 0.45 (0.43−0.47)
P-valueb 0.08 0.14
Elevated non-HDLf (−) 4203 0.47 (0.46−0.47) 0.47 (0.46−0.47)
(+) 2211 0.47 (0.46−0.47) 0.47 (0.46−0.48)
P-valueb 0.66 0.98
CI, confidence interval; DM, diabetes mellitus; HDL, high-density lipoprotein.
aAdjusted for age (year), hours of fasting (< 4, 4–7 and ≥ 8 hours), time of blood drawing (< 12, 12–14 and ≥ 14 hours), season (winter/spring and summer/
autumn) and the listed factors by analysis of covariance.
bOverall difference.
cQuartile category of MET-hours per day (job-related physical activity) or per week (leisure-time physical activity).
dSystolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or use of antihypertensive drugs.
eHbA1c ≥ 6.5% or medication for diabetes mellitus.
fNon-HDL cholesterol ≥ 170 mg/dL.
gP < 0.01 and h P < 0.001 as compared with the lowest category (Dunnett method).
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bin concentrations in women, but not in men, in some
previous studies [10,12], whereas BMI was not correlated
with serum bilirubin in either men or women in a national
survey in the United States [6]. In a large study in the
United Kingdom [7], a decrease in serum bilirubin
seemed to be evident in men and women with overt
obesity. In the present study, bilirubin concentrations
were decreased only in women with the highest BMI (≥
27.5 kg/m2). The findings are thus partly compatible
with the previous observation [7,10,12].
In the Bogalusa Heart Study [13], with adjustment for
sex and race, HDL cholesterol was positively correlated
with serum bilirubin while non-HDL cholesterol was
negatively correlated with serum bilirubin. HDL cholesterol
was also shown to be positively correlated with serum
bilirubin independent of smoking and physical activity
in middle-aged British men [14], but total cholesterol
was not an independent correlate of bilirubin amongTable 3 Multiple linear regression of serum total bilirubin (m
Covariate Men
β (SE)
Diastolic BP (per 10 mmHg) 0.0061 (0.0049)
Non-HDL cholesterol (per 10 mg/dL) −0.0078 (0.0017)
HDL cholesterol (per 10 mg/dL) 0.0165 (0.0040)
HbA1c (per 1.0%) −0.0187 (0.0069)
Use of antihypertensives −0.0313 (0.0138)
Use of cholesterol-lowering drug −0.0779 (0.0201)
Use of antidiabetics −0.0070 (0.0256)
BP, blood pressoure; HDL, high-density lipoprotein.
Included in the model were age (year), hours of fasting (< 4, 4–7 and ≥ 8 hours), tim
summer/autumn), smoking (never, past and current smokers with < 15, 15–29 and
consumption of < 25, 25–49 and ≥ 50 g/day), body mass index (< 22.5, 22.5–24.9, 2
(quartiles), coffee (0, < 1, 1–3, 4–6 and ≥ 7 cups/day), tea (< 1, 1–3, 4–6, 7–9 and ≥them. Neither apolipoprotein A1 nor apolipoprotein B was
correlated with serum bilirubin in another multivariate
analysis [15]. A positive association between HDL chol-
esterol and bilirubin was reported in other studies based
on univariate or age-adjusted analysis [11,12], but not
consistently [10]. In these studies [10-12], total cholesterol
was negatively correlated with serum bilirubin except for
women in one study [12]. The present study showed an
independent positive association between HDL choles-
terol and serum bilirubin. HDL cholesterol seemed to
be more important as correlate of serum bilirubin in
women than in men, but we have no clear expla-
nation for the gender-difference in the association. As
reported previously [21], HbA1c was negatively corre-
lated with serum bilirubin, but the contribution to the
variation of serum bilirubin was much smaller than
HDL cholesterol.
As shown previously [24-26], hours of fasting and time
of blood sampling affected bilirubin concentrations to ag/dL) in natural logarithm on clinical covariates
Women
P β (SE) P
0.22 0.0100 (0.0040) 0.01
< 0.0001 0.0018 (0.0014) 0.19
< 0.0001 0.0252 (0.0029) < 0.0001
0.007 −0.0411 (0.0087) < 0.0001
0.02 0.0051 (0.0124) 0.68
0.0001 0.0258 (0.0128) 0.05
0.78 0.0467 (0.0309) 0.13
e of blood drawing (< 12, 12–14 and ≥ 14 hours), season (winter/spring and
≥ 30 cigarettes/day), alcohol intake (never, past and current drinkers with a
5.0–27.4 and ≥ 27.5 kg/m 2), job-related and leisure-time physical activities
10 cups/day) and all of the listed variables.
Table 4 Relative contribution of behavioral and clinical correlates to the variation of total bilirubin concentrations
Variable (category or unit) Contribution fraction (%)a
Men Women
Fasting hour (< 4, 4–7 and ≥ 8 hours) 7.3 10.2
Time of blood drawing (< 12, 12–14 and ≥ 14 hours) 10.6 33.2
Season (winter/spring and summer/autumn) 2.3 1.5
Smoking (never, past, < 15, 15–29 and ≥ 30 cigarettes/day) 23.7 6.9
Alcohol intake (never, past, < 25, 25–49 and ≥ 50 g/day) 7.9 3.2
BMI (< 22.5, 22.5–24.9, 25.0–27.4 and ≥ 27.5 kg/m2) 1.2 1.6
Work-related activity (quartile of MET-hr/day) 0.9 0.6
Leisure-time activity (quartile of MET-hr/week) 0.3 1.1
Coffee (0, < 1, 1–3, 4–6 and ≥ 7 cups/day) 5.7 6.8
Tea (< 1, 1–3, 4–6, 7–9 and ≥ 10 cups/day) 0.8 0.1
Diastolic blood pressure (mmHg)b 0.2 0.9
Antihypertensive drug (+/−) 0.7 0.0
HbA1c (%)b 1.0 3.1
Antidiabetic drug (+/−) 0.0 0.3
HDL cholesterol (mg/dL)b 2.5 10.1
Non-HDL cholesterol (mg/dL)b 2.9 0.2
Cholesterol-lowering drug (+/−) 2.1 0.6
BMI, body mass index; HDL, high-density lipoprotein.
aProportion of partial R2 for a specific covariate to the overall R2 in the multiple linear regression including age (year) and all of the listed covariates.
bContinuous variables were used.
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did not confound the associations between behavioral and
clinical factors and serum bilirubin.
Among advantages of the present study were a large
size of the study, and multivariate analysis on important
correlates. Several weaknesses should be noted, however.
Information on behavioral factors except BMI was based
on self-report. Such information is always inaccurate to
some extent, but inaccuracy was not substantial to mask
the associations with alcohol and coffee consumption.
Causal inference is difficult for the cross-sectional asso-
ciations, particularly with laboratory measurements.
Comorbid conditions may affect serum bilirubin concen-
trations, lifestyle factors and laboratory measurements.
Thus we excluded individuals who had life-limiting mor-
bid conditions such as atherosclerotic diseases, cancer
and liver disease. Hemoglobin level was not measured in
the present study.Conclusion
Smoking, alcohol use and coffee consumption were found
to be important behavioral correlates in Japanese men
and women. Serum HDL cholesterol was positively associ-
ated with serum bilirubin, being an important contributor
in women.Abbreviations
DM: Diabetes mellitus; HDL: High-density lipoprotein; AST: Aspartate
aminotransferase; ALT: Alanine aminotransferase; MET: Metabolic equivalent;
BMI: Body mass index; CI: Confidence interval.
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